COLO 858 | Vemurafenib | 0.0316 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 373.1 | 4 | 0072-0173 | 930.06 | 173.44 | 334 | 73.60 | 0.775 |
COLO 858 | Vemurafenib | 0.0316 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 2251.8 | 4 | 0073-0171 | 572.45 | 171.06 | 277 | 65.01 | 0.824 |
COLO 858 | Vemurafenib | 0.0316 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 413.1 | 4 | 0074-0175 | 117.62 | 175.02 | 347 | 70.18 | 0.885 |
COLO 858 | Vemurafenib | 0.0316 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 5887.5 | 4 | 0075-0174 | 608.69 | 174.77 | 343 | 72.67 | 0.816 |
COLO 858 | Vemurafenib | 0.0316 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 6898.0 | 4 | 0076-0176 | 709.60 | 175.55 | 246 | 58.77 | 0.895 |
COLO 858 | Vemurafenib | 0.0316 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 753.0 | 4 | 0077-0182 | 743.35 | 181.60 | 249 | 57.94 | 0.932 |
COLO 858 | Vemurafenib | 0.0316 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 390.4 | 4 | 0078-0187 | 260.34 | 187.52 | 305 | 68.43 | 0.819 |
COLO 858 | Vemurafenib | 0.0316 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 4306.2 | 4 | 0079-0187 | 396.30 | 186.68 | 288 | 65.01 | 0.856 |
COLO 858 | Vemurafenib | 0.0316 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 1256.6 | 4 | 0080-0189 | 524.11 | 189.77 | 271 | 62.53 | 0.871 |
COLO 858 | Vemurafenib | 0.0316 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 783.2 | 4 | 0081-0192 | 303.68 | 191.71 | 332 | 70.77 | 0.833 |
COLO 858 | Vemurafenib | 0.0316 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 1035.5 | 4 | 0082-0193 | 77.16 | 194.14 | 250 | 58.87 | 0.906 |
COLO 858 | Vemurafenib | 0.0316 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 1913.1 | 4 | 0083-0204 | 189.14 | 203.70 | 711 | 106.91 | 0.782 |
COLO 858 | Vemurafenib | 0.0316 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 1286.4 | 4 | 0084-0195 | 564.72 | 195.48 | 236 | 56.53 | 0.928 |
COLO 858 | Vemurafenib | 0.0316 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 7990.8 | 4 | 0085-0197 | 603.83 | 197.14 | 195 | 51.70 | 0.917 |
COLO 858 | Vemurafenib | 0.0316 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 586.0 | 4 | 0086-0201 | 361.27 | 201.37 | 278 | 62.18 | 0.903 |
COLO 858 | Vemurafenib | 0.0316 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 2409.4 | 4 | 0087-0203 | 910.95 | 203.03 | 256 | 64.53 | 0.773 |
COLO 858 | Vemurafenib | 0.0316 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 5957.9 | 4 | 0088-0200 | 621.21 | 201.45 | 183 | 52.53 | 0.833 |
COLO 858 | Vemurafenib | 0.0316 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 2364.1 | 4 | 0089-0208 | 451.61 | 208.79 | 227 | 59.94 | 0.794 |
COLO 858 | Vemurafenib | 0.0316 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 3610.7 | 4 | 0090-0205 | 142.26 | 204.59 | 219 | 54.53 | 0.926 |
COLO 858 | Vemurafenib | 0.0316 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 1028.5 | 4 | 0091-0211 | 77.12 | 210.81 | 245 | 58.63 | 0.896 |
COLO 858 | Vemurafenib | 0.0316 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 1450.7 | 4 | 0092-0214 | 212.55 | 213.45 | 279 | 62.53 | 0.897 |
COLO 858 | Vemurafenib | 0.0316 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 531.3 | 4 | 0093-0215 | 882.23 | 215.37 | 291 | 63.36 | 0.911 |
COLO 858 | Vemurafenib | 0.0316 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 1505.2 | 4 | 0094-0218 | 788.07 | 218.22 | 272 | 63.94 | 0.836 |
COLO 858 | Vemurafenib | 0.0316 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 278.7 | 4 | 0095-0220 | 822.27 | 219.43 | 310 | 65.36 | 0.912 |
COLO 858 | Vemurafenib | 0.0316 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 861.2 | 4 | 0096-0221 | 236.96 | 221.31 | 270 | 60.18 | 0.937 |